These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7893906

  • 1. Isoniazid is not always the cause of hepatitis during treatment of tuberculosis.
    van der Kooi K, Mottet JJ, Regamey C.
    Clin Infect Dis; 1994 Nov; 19(5):987-8. PubMed ID: 7893906
    [No Abstract] [Full Text] [Related]

  • 2. Pyrazinamide-induced granulomatous hepatitis.
    Knobel B, Buyanowsky G, Dan M, Zaidel L.
    J Clin Gastroenterol; 1997 Jun; 24(4):264-6. PubMed ID: 9252856
    [Abstract] [Full Text] [Related]

  • 3. [Isoniazid-induced hepatic failure. Report of a case].
    Pereira RM, Tresoldi AT, Hessel G.
    Arq Gastroenterol; 2000 Jun; 37(1):72-5. PubMed ID: 10962632
    [Abstract] [Full Text] [Related]

  • 4. Hepatic complications of antituberculosis therapy revisited.
    Cohen CD, Sayed AR, Kirsch RE.
    S Afr Med J; 1983 Jun 18; 63(25):960-3. PubMed ID: 6857425
    [Abstract] [Full Text] [Related]

  • 5. Pyrazinamide-isoniazid: its apparent influence on the reactivation rate in pulmonary tuberculosis.
    Phillips S.
    Am Rev Respir Dis; 1967 Mar 18; 95(3):503-5. PubMed ID: 6066869
    [No Abstract] [Full Text] [Related]

  • 6. [Hepatic functional changes induced by the combined use of isoniazid, pyrazinamide and rifampicin in the treatment of pulmonary tuberculosis].
    de Souza AF, de Oliveira e Silva A, Baldi J, de Souza TN, Rizzo PM.
    Arq Gastroenterol; 1996 Mar 18; 33(4):194-200. PubMed ID: 9302332
    [Abstract] [Full Text] [Related]

  • 7. [Liver injury under tuberculostatic treatment].
    Fattinger K, Braunschweig S, Reichen J, Meier-Abt PJ, Krähenbühl S.
    Praxis (Bern 1994); 1997 Apr 09; 86(15):626-9. PubMed ID: 9213916
    [Abstract] [Full Text] [Related]

  • 8. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M.
    Kekkaku; 2001 Jan 09; 76(1):33-43. PubMed ID: 11211781
    [Abstract] [Full Text] [Related]

  • 9. Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment.
    van Hest R, Baars H, Kik S, van Gerven P, Trompenaars MC, Kalisvaart N, Keizer S, Borgdorff M, Mensen M, Cobelens F.
    Clin Infect Dis; 2004 Aug 15; 39(4):488-96. PubMed ID: 15356811
    [Abstract] [Full Text] [Related]

  • 10. [Fulminant hepatitis induced by pyrazinamide].
    Roden S, Lagneau M, Homasson JP.
    Rev Pneumol Clin; 1990 Aug 15; 46(1):43. PubMed ID: 2371480
    [No Abstract] [Full Text] [Related]

  • 11. [A clinical investigation of seven patients with pulmonary tuberculosis who developed mixed liver injury during oral anti-tuberculosis treatment].
    Nomi F, Hosaka K, Kurosawa T.
    Kekkaku; 2013 Sep 15; 88(9):647-51. PubMed ID: 24298690
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of drug-induced hepatitis occurring in elderly and younger patients during anti-tuberculosis treatment with a regimen including pyrazinamide].
    Miyazawa N, Horita N, Tomaru K, Tsukahara T, Takahashi R, Sasaki M, Ishigatsubo Y.
    Kekkaku; 2013 Mar 15; 88(3):297-300. PubMed ID: 23672170
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of two pulmonary tuberculosis drug treatments and acetylator status on liver function in a Zimbabwean population.
    Neill P, Pringle D, Mhonda M, Kusema T, Nhachi CF.
    Cent Afr J Med; 1990 Apr 15; 36(4):104-7. PubMed ID: 2225025
    [Abstract] [Full Text] [Related]

  • 16. Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation.
    Farrell FJ, Keeffe EB, Man KM, Imperial JC, Esquivel CO.
    Dig Dis Sci; 1994 Oct 15; 39(10):2255-9. PubMed ID: 7924752
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis cases in isoniazid treated groups and in a control group.
    Riska N.
    Bull Int Union Tuberc; 1976 Oct 15; 51(1):203-8. PubMed ID: 1030282
    [No Abstract] [Full Text] [Related]

  • 18. Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal.
    P V K, Palaian S, Ojha P, P R S.
    Pak J Pharm Sci; 2008 Jan 15; 21(1):51-6. PubMed ID: 18166520
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Letter: Isoniazid hepatitis.
    Stein SC.
    Ann Intern Med; 1974 Mar 15; 80(3):423-4. PubMed ID: 4816197
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.